Stephen Comiskey
Corporate Officer/Principal at SYNERGY PHARMACEUTICALS INC
Network origin in Stephen Comiskey first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 28 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Stephen Comiskey via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Medical Specialties | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
META Group, Inc.
 META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| OKYO PHARMA LIMITED | Biotechnology | Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
| HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder Chief Executive Officer Director/Board Member Director of Finance/CFO | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree | |
Environetics, Inc.
 Environetics, Inc. Wholesale DistributorsDistribution Services Part of Alanco Technologies, Inc., Environetics, Inc. is committed to improving water quality through the development of products which help to solve industrial and municipal water and wastewater quality problems. The company is based in Scottsdale, AZ. The company produces tank & clearwell baffles and covers that provide practical solutions for improving water, wastewater, and air quality. Environetics improves waste treatment by offering a quick, efficient, and satisfactory way to upgrade tank based waste treatment operations through the installation of a Director II system. Environetics was acquired by Alanco Technologies, Inc. on January 06, 1995. | Wholesale Distributors | Director of Finance/CFO | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member Director/Board Member Founder Director/Board Member Director/Board Member | |
| Albany State University (Georgia) | College/University | Graduate Degree | |
| Concordia University | College/University | Undergraduate Degree | |
| Fairfield University | College/University | Undergraduate Degree | |
| St. John's University | College/University | Doctorate Degree | |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Doctorate Degree | |
| University of New Orleans | College/University | Graduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| University of Baroda | College/University | Doctorate Degree Doctorate Degree | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| IBIO, INC. | Pharmaceuticals: Other | Director/Board Member | |
Solta Medical, Inc.
 Solta Medical, Inc. Medical SpecialtiesHealth Technology Solta Medical, Inc. designs, develops, manufactures and markets energy-based medical device systems for aesthetic applications. Its brands include Clear + Brilliant pélo, Thermage, Liposonix, VASER, Fraxel, Clear + Brilliant, and Isolaz systems which are used to address various aesthetic issues. The company was founded by Edward W. Knowlton on January 11, 1996 and is headquartered in Pleasanton, CA. | Medical Specialties | Director of Finance/CFO | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Richard Ivey School of Business | College/University | Masters Business Admin | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Arna Therapeutics Ltd.
 Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Arna Therapeutics Ltd. is a British biotechnology company that focuses on research and experimental development. The private company was founded by Gabriele Marco Antonio Cerrone. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Biotechnology | Director/Board Member Founder | |
| ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director of Finance/CFO | |
| ACTAVIA LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BLUEJAY DIAGNOSTICS, INC. | Medical Specialties | Director/Board Member | |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Biotechnology | Director/Board Member | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Pharmaceuticals: Major | Director/Board Member | |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Biotechnology | Chief Executive Officer | |
Algorithm Sciences, Inc.
 Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Algorithm Sciences, Inc. engages in the business of technology services. The company was founded in 2019 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| Merck & Co. | Real Estate Development | Investor Relations Contact | |
Laidlaw Private Equity, LLC
 Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Venture Partners (Laidlaw Venture) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd. The firm is headquartered in New York. | Investment Managers | Director/Board Member | |
| ACCUSTEM SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
| TIZIANA LIFE SCIENCES LTD | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer |
Statistics
International
| United States | 39 |
| Canada | 5 |
| United Kingdom | 4 |
| Bermuda | 3 |
| Denmark | 2 |
Sectoral
| Health Technology | 33 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Finance | 3 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 105 |
| Corporate Officer/Principal | 56 |
| Independent Dir/Board Member | 36 |
| Chief Tech/Sci/R&D Officer | 30 |
| Chief Executive Officer | 29 |
Most connected contacts
| Insiders | |
|---|---|
| Thomas H. Adams | 22 |
| Gabriele Cerrone | 22 |
| Riccardo Dalla-Favera | 18 |
| John Brancaccio | 17 |
| Christopher McGuigan | 17 |
| Gary Jacob | 16 |
| Richard Daly | 15 |
| Kunwar Shailubhai | 14 |
| Gary Sender | 14 |
| Gary Gemignani | 13 |
| Melvin Spigelman | 11 |
| Bernard Denoyer | 11 |
| Alan F. Joslyn | 11 |
| Timothy Sean Callahan | 9 |
| Dan Dunham | 9 |
- Stock Market
- Insiders
- Stephen Comiskey
- Company connections
